Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_017596869.1 D471_RS0100820 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::A3TGI7 (432 letters) >NCBI__GCF_000341125.1:WP_017596869.1 Length = 427 Score = 479 bits (1234), Expect = e-140 Identities = 245/417 (58%), Positives = 296/417 (70%), Gaps = 2/417 (0%) Query: 6 WTCPAAEGPVAATIDLPGSKSLTNRFLVLAARAGGVSRLRSPLRSRDTLLMAQALGGLGV 65 W P A+ PV+A + LPGSKS+TNR LVLAA + +R PL SRD+ LM AL LGV Sbjct: 12 WHAPTAQRPVSARLSLPGSKSVTNRALVLAALSETPCVVRRPLASRDSELMIGALRALGV 71 Query: 66 GIDDVDGDDWLVTPGEVMGPADIDCGLAGTVMRFVPPLAALARGAVRFDGDPHARTRPMG 125 G+ DG+D +VTP + GPA +D G AGTVMRFVPPLAALA G V FDGDP AR RP+ Sbjct: 72 GVTQ-DGEDLVVTPAALRGPASVDVGNAGTVMRFVPPLAALADGDVHFDGDPRARERPVD 130 Query: 126 PALDALRHLGVDLDDDGRGALPFTVRGTGSVRGGDVTLDASASSQFISALLLSAPHYDQG 185 L+ALR LG D+DD GRGALP T+ GTG+V GG+V LDAS SSQF+SALLLS + QG Sbjct: 131 ELLNALRALGADIDDGGRGALPMTIHGTGAVPGGEVVLDASGSSQFVSALLLSGARFAQG 190 Query: 186 VTIHHQGEPVPSQPHIDMTVEALRDAGADVDDTEADTWRVEPGPLNPLDVQIEPDLSNAA 245 V + HQG PVPSQPH+DMTVE LR G V E ++WRVEPGP+ ++ +EPDLSNAA Sbjct: 191 VHVRHQGPPVPSQPHLDMTVEMLRAVGVSVSTGE-NSWRVEPGPVKATEITVEPDLSNAA 249 Query: 246 PFLAAALVTGGRVRISSWPQHTTQAGDEIRDILDEMGADVSLGRDGLTVSAVDGFSGVDV 305 PFLAAALV+GG V I WP+HTTQ GDE+R + MG +VS LT+ +G+ Sbjct: 250 PFLAAALVSGGEVTIQGWPEHTTQPGDELRSLFTRMGGEVSRSGGDLTLRGTGQVNGITA 309 Query: 306 DLHDASELTPVVAALAALAQGPSLIRGVAHIRGHETDRLAALARELNALGATVTETADGL 365 DL D ELTP +AA+AALA PS + G+AH+R HETDR+AALA E+N LG V E +DGL Sbjct: 310 DLRDVGELTPTIAAVAALADTPSRLTGIAHLRRHETDRIAALAAEINHLGGDVEELSDGL 369 Query: 366 HIVPRPLSPTMFHTYGDHRMVMAGAVIGLAVPGVVIEDVGTVAKTLPTFTDLWAHML 422 I PRPL +FH+Y DHRM +GAVIGL+VPGV +E++ T KTLP F LWA L Sbjct: 370 VIRPRPLHGGVFHSYDDHRMATSGAVIGLSVPGVEVENIATTRKTLPDFPGLWAEAL 426 Lambda K H 0.318 0.136 0.411 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 685 Number of extensions: 40 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 432 Length of database: 427 Length adjustment: 32 Effective length of query: 400 Effective length of database: 395 Effective search space: 158000 Effective search space used: 158000 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate WP_017596869.1 D471_RS0100820 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.10621.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 2.5e-123 397.9 0.0 2.8e-123 397.7 0.0 1.0 1 lcl|NCBI__GCF_000341125.1:WP_017596869.1 D471_RS0100820 3-phosphoshikimat Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000341125.1:WP_017596869.1 D471_RS0100820 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 397.7 0.0 2.8e-123 2.8e-123 2 411 .. 24 424 .. 23 427 .] 0.97 Alignments for each domain: == domain 1 score: 397.7 bits; conditional E-value: 2.8e-123 TIGR01356 2 eikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakveeekeelviegvgglkepe 70 ++++pgsKS+++Ral+laaL+e+++vv+++L s+D + ++ alr+lG+ v++++e+lv+++ + + lcl|NCBI__GCF_000341125.1:WP_017596869.1 24 RLSLPGSKSVTNRALVLAALSETPCVVRRPLASRDSELMIGALRALGVGVTQDGEDLVVTPAA--LRGP 90 5789*********************************************************77..5555 PP TIGR01356 71 aeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgp 139 a++d+gn+Gt++R++ +++ala+g+v+++gd++ ++RP+++l++aLr+lga+i++ +g lP++i+g+ lcl|NCBI__GCF_000341125.1:WP_017596869.1 91 ASVDVGNAGTVMRFVPPLAALADGDVHFDGDPRARERPVDELLNALRALGADIDDGG-RGALPMTIHGT 158 7*****************************************************866.79********9 PP TIGR01356 140 ..lkggivelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederk 206 ++gg v l++s SsQ++salll++++ q+v ++++g ++ s+p++++t+++l++ gv+v+ ++ + lcl|NCBI__GCF_000341125.1:WP_017596869.1 159 gaVPGGEVVLDASGSSQFVSALLLSGARFAQGVHVRHQGPPVPSQPHLDMTVEMLRAVGVSVSTGEN-S 226 99999**********************************************************9875.* PP TIGR01356 207 ivvkggqkykqkevevegDaSsAafflaaaaitgeevtvenlgenstqgdkaiiivLeemGadveveeq 275 ++v++g k +e++ve D+S+Aa flaaa+++g+evt++++ e++tq+++++ +++ +mG++v++ lcl|NCBI__GCF_000341125.1:WP_017596869.1 227 WRVEPGP-VKATEITVEPDLSNAAPFLAAALVSGGEVTIQGWPEHTTQPGDELRSLFTRMGGEVSRSGG 294 *****97.77777******************************************************** PP TIGR01356 276 rdvevegasklkgvkvdidvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGv 344 d++++g+ +++g++ +d+ ++ +++pt+a++aa+A++++r+++i++lR +E+dRiaa+a+e+++lG lcl|NCBI__GCF_000341125.1:WP_017596869.1 295 -DLTLRGTGQVNGIT--ADLRDVGELTPTIAAVAALADTPSRLTGIAHLRRHETDRIAALAAEINHLGG 360 .8*************..**************************************************** PP TIGR01356 345 eveeledgllieGkkkelkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleq 411 +veel+dgl+i+++ l+g+v ++ydDHR+a++ av+gl + +ve+e+ ++++k+ P+F ++++ lcl|NCBI__GCF_000341125.1:WP_017596869.1 361 DVEELSDGLVIRPRP--LHGGVFHSYDDHRMATSGAVIGLSVP-GVEVENIATTRKTLPDFPGLWAE 424 **************5..*************************9.*****************877765 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (427 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 10.26 // [ok]
This GapMind analysis is from Apr 10 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory